Routine Blood Pressure Checks
Hypertension patients on lacosamide need regular blood pressure monitoring, as the drug can cause dizziness, ataxia, or PR interval prolongation, potentially worsening hypotension or interacting with antihypertensive meds. Guidelines recommend weekly home checks initially, then biweekly, alongside clinic visits every 1-3 months to track trends and adjust therapy.[1][2]
Cardiac Monitoring
Lacosamide prolongs the PR interval in up to 10% of patients, raising atrioventricular block risk—critical for those with hypertension and cardiovascular comorbidity. Baseline ECG is required before starting, with follow-ups at 1 month, then every 6 months or if symptoms like syncope arise. Continuous ECG if history of conduction issues.[2][3]
Electrolyte and Renal Function Tests
Hypertensive patients often take diuretics, which can interact with lacosamide's sodium channel effects, risking hyponatremia or kidney strain. Monitor serum sodium, potassium, creatinine, and eGFR at baseline, 1-2 weeks after initiation, then monthly for 3 months, quarterly thereafter. More frequent if dose >400 mg/day.[1][4]
Neurological Assessments
Seizure control is primary, but hypertension patients face higher falls risk from lacosamide-induced dizziness (common at >200 mg/day). Track seizure frequency, gait stability, and cognitive changes via patient logs and clinician exams at each visit. EEG if breakthrough seizures occur.[2]
What If Interactions Occur with Antihypertensives?
Lacosamide has minimal CYP interactions but may amplify effects of beta-blockers or calcium channel blockers via additive cardiac slowing. Review full med list at every visit; dose adjustments or ECG may be needed. No routine liver enzyme monitoring unless baseline abnormalities.[3][4]
Frequency Adjustments by Risk Level